Precigen, Inc. (PGEN)
NASDAQ: PGEN · IEX Real-Time Price · USD
1.415
+0.015 (1.07%)
May 3, 2024, 10:34 AM EDT - Market open

Precigen Revenue

In the year 2023, Precigen had annual revenue of $6.23M, a decrease of -76.87%. Revenue in the quarter ending December 31, 2023 was $1.23M, a -30.35% decrease year-over-year.

Revenue (ttm)
$6.23M
Revenue Growth
-76.87%
P/S Ratio
56.77
Revenue / Employee
$30,817
Employees
202
Market Cap
358.44M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20236.23M-20.68M-76.87%
Dec 31, 202226.91M12.64M88.61%
Dec 31, 202114.27M-17.73M-55.40%
Dec 31, 202031.99M-58.73M-64.74%
Dec 31, 201990.72M-60.46M-39.99%
Dec 31, 2018151.18M-68.29M-31.11%
Dec 31, 2017219.46M28.54M14.95%
Dec 31, 2016190.93M17.32M9.98%
Dec 31, 2015173.61M101.68M141.35%
Dec 31, 201471.93M48.17M202.74%
Dec 31, 201323.76M9.99M72.50%
Dec 31, 201213.77M5.76M71.90%
Dec 31, 20118.01M--
Dec 31, 20100--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
ModivCare 2.76B
Zynex 184.32M
Surmodics 138.20M
Heron Therapeutics 127.04M
CVRx, Inc. 39.30M
Immutep 4.58M
Q32 Bio 1.16M
Revenue Rankings